MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents
Journal of Gastroenterology · 2024
DOI: 10.1007/s00535-024-02115-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology, 2024. Verfasst von Takanori Suzuki und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho, Nagoya, Aichi, 467-86…. Hauptthemen laut MEDLINE: Liver Cirrhosis, MicroRNAs, Antiviral Agents, Hepatitis C, Chronic. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
BACKGROUND: We retrospectively investigated microRNA (miRNA) levels in serum-derived extracellular vesicles (EVs) as predictive indicators for regression of liver fibrosis, after achievement of a sustained virological response (SVR) by direct-acting antiviral (DAA) therapy for chronic hepatitis C (CHC). METHODS: The study subjects were recruited from a historical cohort of 108 CHC patients whose pretreatment serum Mac-2-binding protein glycosylation isomer (M2BPGi) levels were ≥ 2.0 cut-off index (COI). We classified patients with M2BPGi levels < 1.76 and ≥ 1.76 COI at 2 years after the end of treatment (EOT) into the regression and non-regression groups, respectively. Eleven of the patients were assigned to the discovery set, and we comprehensively investigated the miRNAs contained in serum-derived EVs at 24 weeks after the EOT (EOT24W), using RNA sequencing. The remaining 97 patients were assigned to the validation set, and reproducibility was verified by quantitative real-time PCR. RESULTS: Through analysis of the discovery and validation sets, we identified miR-223-3p and miR-1290 as candidate predictors. Subsequently, we analyzed various clinical data, including these candidate miRNAs. Multivariate analyses revealed that the levels of miR-223-3p at EOT24W were significantly associated with regression of M2BPGi-based liver fibrosis (Odds ratio: 1.380; P = 0.024). Consistent results were obtained, even when the serum M2BPGi levels were aligned by propensity score matching and in patients with advanced M2BPGi-based liver fibrosis (pretreatment M2BPGi levels ≥ 3.3 COI). CONCLUSIONS: The miR-223-3p level in serum-derived EVs at EOT24W is a feasible predictor of regression of M2BPGi-based liver fibrosis after achievement of an SVR by DAA therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho, Nagoya, Aichi, 467-8601, Japan.
- Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho, Nagoya, Aichi, 467-8601, Japan. matsuura@med.nagoya-cu.ac.jp.
- Department of Gastroenterology, Kasugai Municipal Hospital, Kasugai, Japan.
- Department of Virology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
- Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Suzuki, T., Matsuura, K., Nagura, Y., Ito, K., Ogawa, S., Kawamura, H., Fujiwara, K., Nagaoka, K., Iio, E., Watanabe, T., Kataoka, H., & Tanaka, Y. (2024). MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents. Journal of Gastroenterology. https://doi.org/10.1007/s00535-024-02115-w
Vancouver
Suzuki T, Matsuura K, Nagura Y, Ito K, Ogawa S, Kawamura H, et al. MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents. Journal of Gastroenterology. 2024. doi:10.1007/s00535-024-02115-w
BibTeX
@article{Suzuki2024,
author = {Suzuki, Takanori and Matsuura, Kentaro and Nagura, Yoshihito and Ito, Kyoko and Ogawa, Shintaro and Kawamura, Hayato and Fujiwara, Kei and Nagaoka, Katsuya and Iio, Etsuko and Watanabe, Takehisa and Kataoka, Hiromi and Tanaka, Yasuhito},
title = {MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents},
journal = {Journal of Gastroenterology},
year = {2024},
doi = {10.1007/s00535-024-02115-w}
}
EUVIMED